Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension

Steven H. Abman, John P. Kinsella, Erika B. Rosenzweig, Usha Krishnan, Thomas Kulik, Mary Mullen, David L. Wessel, Robin H Steinhorn, Ian Adatia, Brian Hanna, Jeffrey Feinstein, Jeffrey Fineman, Usha Raj, Tilman Humpl

Research output: Contribution to journalArticle

72 Scopus citations

Fingerprint Dive into the research topics of 'Implications of the U.S. Food and Drug Administration warning against the use of sildenafil for the treatment of pediatric pulmonary hypertension'. Together they form a unique fingerprint.

Medicine & Life Sciences